CompletedPHASE1, PHASE2NCT00459316
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Studying Meningococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- George K. Siberry, MD, MPHPediatric, Adolescent, and Maternal AIDS (PAMA) Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
- Intervention
- Quadrivalent meningococcal conjugate vaccine(biological)
- Enrollment
- 384 target
- Eligibility
- 2-24 years · All sexes
- Timeline
- 2007 – 2013
Study locations (30)
- Usc La Nichd Crs, Alhambra, California, United States
- Miller Children's Hosp. Long Beach CA NICHD CRS, Long Beach, California, United States
- Children's Hospital of Los Angeles NICHD CRS, Los Angeles, California, United States
- UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States
- University of California, UC San Diego CRS, San Diego, California, United States
- Univ. of California San Francisco NICHD CRS, San Francisco, California, United States
- Harbor UCLA Medical Ctr. NICHD CRS, Torrance, California, United States
- Univ. of Colorado Denver NICHD CRS, Aurora, Colorado, United States
- Children's National Med. Ctr. Washington DC NICHD CRS, Washington D.C., District of Columbia, United States
- Howard Univ. Washington DC NICHD CRS, Washington D.C., District of Columbia, United States
- South Florida CDTC Ft Lauderdale NICHD CRS, Fort Lauderdale, Florida, United States
- Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States
- Pediatric Perinatal HIV Clinical Trials Unit CRS, Miami, Florida, United States
- USF - Tampa NICHD CRS, Tampa, Florida, United States
- Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00459316 on ClinicalTrials.govOther trials for Meningococcal meningitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT06995430A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)GlaxoSmithKline
- RECRUITINGPHASE4NCT06832514Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender PersonsUniversity Ghent
- ACTIVE NOT RECRUITINGPHASE3NCT06700148A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year OldsCanSino Biologics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06131554A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 YearsCanSino Biologics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06226714A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year OldsCanSino Biologics Inc.
- RECRUITINGNCT04664569National Bacterial Meningitis StudyAssociation Clinique Thérapeutique Infantile du val de Marne